
Sign up to save your podcasts
Or


This week on BioTech Nation, Dr. Amit Kumar, President and CEO of Anixa Biosciences, talks about their work on a breast cancer vaccine which targets a protein thought only to be expressed during breastfeeding. Building on research by the Cleveland Clinic, Dr. Kumar describes ongoing human clinical trials and their potential for women with BRCA mutations.
By Moira Gunn4.1
2929 ratings
This week on BioTech Nation, Dr. Amit Kumar, President and CEO of Anixa Biosciences, talks about their work on a breast cancer vaccine which targets a protein thought only to be expressed during breastfeeding. Building on research by the Cleveland Clinic, Dr. Kumar describes ongoing human clinical trials and their potential for women with BRCA mutations.

21,972 Listeners

43,860 Listeners

32,012 Listeners

30,713 Listeners

43,592 Listeners

707 Listeners

6,409 Listeners

30,219 Listeners

125 Listeners

320 Listeners

9,930 Listeners

34 Listeners

18 Listeners

48 Listeners

138 Listeners